{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:59:32Z","timestamp":1789991972944,"version":"4.0.1"},"update-to":[{"DOI":"10.1002\/14651858.cd002919.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000}}],"reference-count":89,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd002919.pub3","type":"journal-article","created":{"date-parts":[[2015,4,3]],"date-time":"2015-04-03T10:36:12Z","timestamp":1428057372000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults"],"prefix":"10.1002","volume":"2019","author":[{"given":"Rita","family":"Banzi","sequence":"first","affiliation":[{"name":"IRCCS - Mario Negri Institute for Pharmacological Research; Laboratory of Regulatory Policies; via G La Masa 19 Milan Italy 20156"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Cusi","sequence":"additional","affiliation":[{"name":"Istituti Clinici di Perfezionamento; Out Patient Services - Neurology; Via Castelvetro 22 Milano Italy 20154"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concetta","family":"Randazzo","sequence":"additional","affiliation":[{"name":"University of Bologna; Department of Biomedical and Neuromotor Sciences; Via San Giacomo, 12 Bologna Italy 40126"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Sterzi","sequence":"additional","affiliation":[{"name":"Azienda Ospedaliera Niguarda; Neuroscience Department; Piazza Ospedale Maggiore, 3 Milano Italy 20163"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Tedesco","sequence":"additional","affiliation":[{"name":"University of Bologna; Department of Biomedical and Neuromotor Sciences; Via San Giacomo, 12 Bologna Italy 40126"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Moja","sequence":"additional","affiliation":[{"name":"University of Milan; Department of Biomedical Sciences for Health; Via Pascal 36 Milan Milan Italy 20133"},{"name":"IRCCS Galeazzi Orthopaedic Institute; Unit of Clinical Epidemiology; Milan Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,4,1]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD002919.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1526-4610.1992.hed3202101.x","article-title":"Fluoxetine prophylaxis of migraine","volume":"32","author":"Adly","year":"1992","journal-title":"Headache"},{"issue":"8","key":"10.1002\/14651858.CD002919.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1526-4610.1994.hed3408476.x","article-title":"A comparative study of amitriptyline and fluvoxamine in migraine prophylaxis","volume":"34","author":"Bank","year":"1994","journal-title":"Headache"},{"key":"10.1002\/14651858.CD002919.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"44\u20138","DOI":"10.1016\/j.clineuro.2004.03.004","article-title":"Venlafaxine versus amitriptyline in the prophylactic treatment of migraine: randomized, double-blind, crossover study","volume":"107","author":"Bulut","year":"2004","journal-title":"Clinical Neurology and Neurosurgery"},{"issue":"10","key":"10.1002\/14651858.CD002919.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1046\/j.1526-4610.1999.3910716.x","article-title":"Fluoxetine for migraine prophylaxis: a double-blind trial","volume":"39","author":"Colucci d'Amato","year":"1999","journal-title":"Headache"},{"issue":"6","key":"10.1002\/14651858.CD002919.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1046\/j.1526-4610.2002.02125.x","article-title":"Amitriptyline versus amitriptyline combined with fluoxetine in the preventative treatment of transformed migraine: a double-blind study","volume":"42","author":"Krymchantowski","year":"2002","journal-title":"Headache"},{"issue":"1","key":"10.1002\/14651858.CD002919.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1046\/j.1526-4610.1999.3901028.x","article-title":"Selective serotonin reuptake inhibitors for migraine prophylaxis","volume":"39","author":"Landy","year":"1999","journal-title":"Headache"},{"issue":"5","key":"10.1002\/14651858.CD002919.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1046\/j.1468-2982.1999.019005531.x","article-title":"Use of amitriptyline and fluoxetine in prophylaxis of migraine and tension-type headaches","volume":"19","author":"Oguzhanoglu","year":"1999","journal-title":"Cephalalgia"},{"issue":"5","key":"10.1002\/14651858.CD002919.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1526-4610.2005.05029.x","article-title":"The efficacy and safety of venlafaxine in the prophylaxis of migraine","volume":"45","author":"Ozyalcin","year":"2005","journal-title":"Headache"},{"issue":"9","key":"10.1002\/14651858.CD002919.pub3-BIB0009|cit9","first-page":"408","article-title":"Fluoxetine in the treatment of migraine with interval headache","volume":"72","author":"Polisca","year":"1992","journal-title":"Rassegna Internazionale di Clinica e Terapia"},{"issue":"5","key":"10.1002\/14651858.CD002919.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1046\/j.1468-2982.1998.1805283.x","article-title":"S-fluoxetine in the prophylaxis of migraine: a phase II double-blind randomized placebo-controlled study","volume":"18","author":"Steiner","year":"1998","journal-title":"Cephalalgia"},{"key":"10.1002\/14651858.CD002919.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/WNF.0b013e3181a8c84f","article-title":"Escitalopram and venlafaxine for the prophylaxis of migraine headache without mood disorders","volume":"32","author":"Tarlaci","year":"2009","journal-title":"Clinical Neuropharmacology"},{"issue":"8","key":"10.1002\/14651858.CD002919.pub3-BIB0012|cit12","first-page":"20","article-title":"A comparative efficiency of amitriptyline, fluoxetine and maprotiline in prevention of migraine in attack-free period","volume":"100","author":"Amelin","year":"2000","journal-title":"Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova"},{"issue":"4","key":"10.1002\/14651858.CD002919.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1600-0404.1981.tb04407.x","article-title":"Propranolol and femoxetine, a 5-HT-uptake inhibitor, in migraine prophylaxis. A double-blind crossover study","volume":"64","author":"Andersson","year":"1981","journal-title":"Acta Neurologica Scandinavica"},{"issue":"1","key":"10.1002\/14651858.CD002919.pub3-BIB0014|cit14","first-page":"82","article-title":"Fluoxetine: side effects and efficacy in a headache population","volume":"3","author":"Bittman","year":"1992","journal-title":"Headache Quarterly"},{"key":"10.1002\/14651858.CD002919.pub3-BIB0015|cit15","first-page":"265","article-title":"Effectiveness of fluoxetine on pain and depression in chronic headache disorders","volume-title":"Headache and Depression: Serotonin Pathways as a Common Clue","author":"Bussone","year":"1991"},{"issue":"1","key":"10.1002\/14651858.CD002919.pub3-BIB0016|cit16","first-page":"3","article-title":"Venlafaxine, serotonin and norepinephrine reuptake inhibitor for preventive migraine without aura treatment: a preliminary study","volume":"45","author":"Centonze","year":"2000","journal-title":"Medicina Psicosomatica"},{"issue":"3","key":"10.1002\/14651858.CD002919.pub3-BIB0017|cit17","first-page":"266","article-title":"Paroxetine versus flunarizine in the preventive treatment of migraine","volume":"9","author":"Colucci d'Amato","year":"1998","journal-title":"Headache Quarterly"},{"key":"10.1002\/14651858.CD002919.pub3-BIB0018|cit18","unstructured":"Colucci d'Amato C Pizza V Marmolo T Giordano E Alfano V Ruggiero A Experience of treatment with SSRI in migraine prophylaxis Atti del 14\u00b0 congresso Nazionale della Societa' Italiana per lo studio delle cefalee; 1999 sett 19-22; Perugia 1999 79"},{"issue":"3","key":"10.1002\/14651858.CD002919.pub3-BIB0019|cit19","first-page":"213","article-title":"Migraine prophylactic therapy: citalopram versus flunarizine","volume":"11","author":"Colucci d'Amato","year":"2000","journal-title":"Headache Quarterly"},{"issue":"2","key":"10.1002\/14651858.CD002919.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/00002508-198906000-00013","article-title":"The use of fluoxetine in the treatment of headache","volume":"5","author":"Diamond","year":"1989","journal-title":"Clinical Journal of Pain"},{"issue":"10","key":"10.1002\/14651858.CD002919.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1526-4610.1994.hed3410587.x","article-title":"Paroxetine in the treatment of chronic daily headache","volume":"34","author":"Foster","year":"1994","journal-title":"Headache"},{"key":"10.1002\/14651858.CD002919.pub3-BIB0022|cit22","first-page":"73","article-title":"Efficacy and tolerability of citalopram in chronic headache syndrome prophylaxis","author":"Iannacchero","year":"1999","journal-title":"Psichiatria"},{"issue":"4","key":"10.1002\/14651858.CD002919.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1600-0404.1983.tb04836.x","article-title":"Femoxetine - a new 5-HT uptake inhibitor - and propranolol in the prophylactic treatment of migraine","volume":"68","author":"Kangasniemi","year":"1983","journal-title":"Acta Neurologica Scandinavica"},{"issue":"3","key":"10.1002\/14651858.CD002919.pub3-BIB0024|cit24","first-page":"265","article-title":"Role of SSRIs in the management of migraine","volume":"9","author":"Kathpal","year":"1998","journal-title":"Headache Quarterly"},{"issue":"3","key":"10.1002\/14651858.CD002919.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1600-0404.1986.tb07861.x","article-title":"A randomized general practice group-comparative study of femoxetine and placebo in the prophylaxis of migraine","volume":"74","author":"Orholm","year":"1986","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1002\/14651858.CD002919.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000080960","article-title":"Evaluation of the prophylactic efficacy of amitriptyline and citalopram, alone or in combination, in patients with comorbidity of depression, migraine, and tension-type headache","volume":"50","author":"Rampello","year":"2004","journal-title":"Neuropsychobiology"},{"key":"10.1002\/14651858.CD002919.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1177\/0333102491011S11150","article-title":"Antalgic and antidepressant activities of fluoxetine in daily chronic headache","volume":"11 Suppl 11","author":"Sandrini","year":"1991","journal-title":"Cephalalgia"},{"issue":"9","key":"10.1002\/14651858.CD002919.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1526-4610.1994.hed3409497.x","article-title":"Double-blind trial of fluoxetine: chronic daily headache and migraine","volume":"34","author":"Saper","year":"1994","journal-title":"Headache"},{"issue":"6","key":"10.1002\/14651858.CD002919.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1600-0404.1981.tb04423.x","article-title":"Femoxetine in the prophylaxis of migraine - a randomised comparison with placebo","volume":"64","author":"Zeeberg","year":"1981","journal-title":"Acta Neurologica Scandinavica"},{"issue":"3","key":"10.1002\/14651858.CD002919.pub3-BIB0030|cit30","first-page":"55\u2013334","article-title":"Selective serotonin reuptake inhibitor venlafaxine as a prophylactic drug for migraine without aura","volume":"16","author":"Dzagnidze","year":"2009","journal-title":"European Journal of Neurology"},{"issue":"25","key":"10.1002\/14651858.CD002919.pub3-BIB0031|cit31","first-page":"5254","article-title":"Curative effect of fluoxetine for adjuvant treatment of migraine and its effect on serum lipid","volume":"8","author":"He","year":"2004","journal-title":"Chinese Journal of Clinical Rehabilitation"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD002919.pub3-BIB0032|cit32","first-page":"142","article-title":"The profilaxis of the frequency of migraine attacks with sertraline and cinarizine","volume":"29","author":"Stanic","year":"2009","journal-title":"Cephalalgia"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD002919.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"G38","DOI":"10.1186\/1129-2377-15-S1-G38","article-title":"Efficacy and safety of venlafaxine for the treatment of chronic migraine: a randomized, double-blind, controlled trial","volume":"15","author":"Togha","year":"2014","journal-title":"Journal of Headache and Pain"},{"key":"10.1002\/14651858.CD002919.pub3-BIB0034|cit34","unstructured":"Milnacipran for migraine pain https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01393522 (accessed November 2014)"},{"issue":"9","key":"10.1002\/14651858.CD002919.pub3-BIB0035|cit35","first-page":"717","article-title":"Classification of headache","volume":"179","author":"Ad Hoc Committee on the Classification of Headache of the National Institute of Neurological Diseases and Blindness","year":"1962","journal-title":"JAMA"},{"issue":"8682","key":"10.1002\/14651858.CD002919.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0140-6736(90)90014-V","article-title":"Randomisation and baseline comparisons in clinical trials","volume":"335","author":"Altman","year":"1990","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD002919.pub3-BIB0037|cit37","unstructured":"American Migraine Foundation 36 Million Migraine Campaign http:\/\/www.americanmigrainefoundation.org\/support-the-foundation\/36-million-migraine-campaign\/ (accessed January 2015)"},{"issue":"5","key":"10.1002\/14651858.CD002919.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10194-012-0460-7","article-title":"Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS)","volume":"13","author":"Bloudek","year":"2012","journal-title":"Journal of Headache and Pain"},{"issue":"1","key":"10.1002\/14651858.CD002919.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1526-4610.2011.02046.x","article-title":"Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study","volume":"52","author":"Buse","year":"2012","journal-title":"Headache"},{"issue":"8","key":"10.1002\/14651858.CD002919.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1007\/s00415-012-6725-x","article-title":"Psychiatric comorbidities of episodic and chronic migraine","volume":"260","author":"Buse","year":"2013","journal-title":"Journal of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD002919.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/oxfordjournals.qjmed.a030141","article-title":"Economic and social impact of migraine","volume":"89","author":"Clarke","year":"1996","journal-title":"QJM: Monthly Journal of the Association of Physicians"},{"key":"10.1002\/14651858.CD002919.pub3-BIB0042|cit42","volume-title":"Statistical Power Analysis in the Behavioral Sciences","author":"Cohen","year":"1988"},{"key":"10.1002\/14651858.CD002919.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1338\u201342","DOI":"10.1212\/01.WNL.0000120545.45443.93","article-title":"Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life","volume":"62","author":"Colas","year":"2004","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD002919.pub3-BIB0044|cit44","first-page":"103","article-title":"The economic cost of migraine","volume":"2","author":"Cull","year":"1992","journal-title":"British Journal of Medical Economics"},{"key":"10.1002\/14651858.CD002919.pub3-BIB0045|cit45","unstructured":"Deeks JJ Higgins JPT Altman DG (editors) Chapter 9: Analysing data and undertaking meta-analyses In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"issue":"1","key":"10.1002\/14651858.CD002919.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"9","key":"10.1002\/14651858.CD002919.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/j.1468-1331.2009.02748.x","article-title":"European Federation of Neurological Societies (EFNS) guideline on the drug treatment of migraine \u2013 revised report of an EFNS task force","volume":"16","author":"Evers","year":"2009","journal-title":"European Journal of Neurology"},{"issue":"7652","key":"10.1002\/14651858.CD002919.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/bmj.39493.646875.AE","article-title":"GRADE Working Group. Rating quality of evidence and strength of recommendations: Going from evidence to recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"11","key":"10.1002\/14651858.CD002919.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/j.1468-2982.2007.01476.x","article-title":"Serotonin and migraine: biology and clinical implications","volume":"27","author":"Hamel","year":"2007","journal-title":"Cephalalgia"},{"key":"10.1002\/14651858.CD002919.pub3-BIB0050|cit50","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD002919.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"11\u20137","DOI":"10.1007\/s40263-013-0126-2","article-title":"Emerging targets in migraine","volume":"28","author":"Hoffmann","year":"2014","journal-title":"CNS Drugs"},{"issue":"4","key":"10.1002\/14651858.CD002919.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/jech.51.4.354","article-title":"Putting trials on trial - the costs and consequences of small trials in depression: a systematic review of methodology","volume":"51","author":"Hotopf","year":"1997","journal-title":"Journal of Epidemiology & Community Health"},{"key":"10.1002\/14651858.CD002919.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1192\/bjp.175.3.217","article-title":"Pragmatic randomised controlled trials in psychiatry","volume":"175","author":"Hotopf","year":"1999","journal-title":"British Journal of Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD002919.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/archinte.159.8.813","article-title":"Burden of migraine in the United States: disability and economic costs","volume":"159","author":"Hu","year":"1999","journal-title":"Archives of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD002919.pub3-BIB0055|cit55","first-page":"1\u2013160","article-title":"The International Classification of Headache Disorders: 2nd edition","volume":"24 Suppl","author":"Headache Classification Subcommittee of the International Headache Society","year":"2004","journal-title":"Cephalalgia"},{"issue":"7","key":"10.1002\/14651858.CD002919.pub3-BIB0056|cit56","first-page":"1","article-title":"Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain","volume":"8 Suppl","author":"Headache Classification Committee of the International Headache Society","year":"1988","journal-title":"Cephalalgia"},{"issue":"9","key":"10.1002\/14651858.CD002919.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"629\u2013808","DOI":"10.1177\/0333102413485658","article-title":"The International Classification of Headache Disorders, 3rd edition (beta version)","volume":"33","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2013","journal-title":"Cephalalgia"},{"key":"10.1002\/14651858.CD002919.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"c5222","DOI":"10.1136\/bmj.c5222","article-title":"Tricyclic antidepressants and headaches: systematic review and meta-analysis","volume":"341","author":"Jackson","year":"2010","journal-title":"BMJ"},{"issue":"11","key":"10.1002\/14651858.CD002919.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1001\/jama.289.11.1430","article-title":"Headache assessment and management","volume":"289","author":"Kaniecki","year":"2003","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD002919.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1468-1331.2011.03612.x","article-title":"The cost of headache disorders in Europe: the Eurolight project","volume":"19","author":"Linde","year":"2012","journal-title":"European Journal of Neurology"},{"issue":"7","key":"10.1002\/14651858.CD002919.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1046\/j.1526-4610.2001.041007646.x","article-title":"Prevalence and burden of migraine in the United States: data from the American Migraine Study II","volume":"41","author":"Lipton","year":"2001","journal-title":"Headache"},{"key":"10.1002\/14651858.CD002919.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"493\u20134","DOI":"10.1001\/jama.291.4.493","article-title":"Is migraine a progressive brain disease?","volume":"291","author":"Lipton","year":"2004","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD002919.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1212\/01.wnl.0000252808.97649.21","article-title":"Migraine prevalence, disease burden, and the need for preventive therapy","volume":"68","author":"Lipton","year":"2007","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD002919.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1526-4610.2012.02185.x","article-title":"The 2012 AHS\/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines","volume":"52","author":"Loder","year":"2012","journal-title":"Headache"},{"issue":"4","key":"10.1002\/14651858.CD002919.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1526-4610.2009.01369.x","article-title":"Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study","volume":"49","author":"Munakata","year":"2009","journal-title":"Headache"},{"key":"10.1002\/14651858.CD002919.pub3-BIB0066|cit66","volume-title":"Headache: Diagnostic System and Taxonomic Criteria","author":"Nappi","year":"1985"},{"issue":"5","key":"10.1002\/14651858.CD002919.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"599\u2013609","DOI":"10.1111\/j.1468-2982.2009.01941.x","article-title":"Global prevalence of chronic migraine: a systematic review","volume":"30","author":"Natoli","year":"2010","journal-title":"Cephalalgia"},{"key":"10.1002\/14651858.CD002919.pub3-BIB0068|cit68","unstructured":"National Institute of Health and Care Excellence Headaches: diagnosis and management of headaches in young people and adults Clinical guidelines, CG150 September 2012 187 214"},{"issue":"6","key":"10.1002\/14651858.CD002919.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0197-2456(97)00008-1","article-title":"Clinical trials with multiple outcomes: a statistical perspective on their design, analysis, and interpretation","volume":"18","author":"Pocock","year":"1997","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD002919.pub3-BIB0070|cit70","first-page":"S1","article-title":"Canadian Headache Society Guideline for Migraine Prophylaxis","volume":"39 Suppl 2","author":"Pringsheim","year":"2012","journal-title":"Canadian Journal of Neurological Sciences"},{"key":"10.1002\/14651858.CD002919.pub3-BIB0071|cit71","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"1","key":"10.1002\/14651858.CD002919.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jval.2012.08.2212","article-title":"Cost and predictors of lost productive time in chronic migraine and episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study","volume":"16","author":"Serrano","year":"2013","journal-title":"Value in Health"},{"key":"10.1002\/14651858.CD002919.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1212\/WNL.47.4.871","article-title":"Classification of daily and near-daily headaches: field trial of revised IHS criteria","volume":"47","author":"Silberstein","year":"1996","journal-title":"Neurology"},{"issue":"17","key":"10.1002\/14651858.CD002919.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1212\/WNL.0b013e3182535d20","article-title":"Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society","volume":"78","author":"Silberstein","year":"2012","journal-title":"Neurology"},{"issue":"7","key":"10.1002\/14651858.CD002919.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1212\/WNL.55.7.915","article-title":"Pharmacologic treatment of pain in polyneuropathy","volume":"55","author":"Sindrup","year":"2000","journal-title":"Neurology"},{"issue":"10","key":"10.1002\/14651858.CD002919.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"840","DOI":"10.7326\/0003-4819-137-10-200211190-00014","article-title":"Pharmacologic management of acute attacks of migraine and prevention of migraine headache","volume":"137","author":"Snow","year":"2002","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD002919.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1741-7015-7-71","article-title":"Migraine pathogenesis and state of pharmacological treatment options","volume":"7","author":"Sprenger","year":"2009","journal-title":"BMC Medicine"},{"issue":"1","key":"10.1002\/14651858.CD002919.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1129-2377-14-1","article-title":"Migraine: the seventh disabler","volume":"14","author":"Steiner","year":"2013","journal-title":"Journal of Headache and Pain"},{"issue":"1","key":"10.1002\/14651858.CD002919.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/jama.1992.03480010072027","article-title":"Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors","volume":"267","author":"Stewart","year":"1992","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD002919.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/0333102411417901","article-title":"Guidelines for controlled trials of drugs in migraine: third edition. A guide for investigators","volume":"32","author":"Tfelt-Hansen","year":"2012","journal-title":"Cephalalgia"},{"issue":"7167","key":"10.1002\/14651858.CD002919.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1136\/bmj.317.7167.1181","article-title":"Content and quality of 2000 controlled trials in schizophrenia over 50 years","volume":"317","author":"Thornley","year":"1998","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD002919.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0002-9343(01)00762-8","article-title":"Treatment of chronic headache with antidepressants: a meta-analysis","volume":"111","author":"Tomkins","year":"2001","journal-title":"American Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD002919.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1212\/WNL.50.6.1741","article-title":"Migraine and reduced work performance: a population-based study","volume":"50","author":"Korff","year":"1998","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD002919.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"2163\u201396","DOI":"10.1016\/S0140-6736(12)61729-2","article-title":"Years lived with disability (YLD) for 1160 sequelae of 289 diseases and injuries 1990\u20132010: a systematic analysis for the global burden of disease study 2010","volume":"380","author":"Vos","year":"2012","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD002919.pub3-BIB0085|cit85","first-page":"1434\u201342","article-title":"Chronic frequent headache in the general population: prevalence and associated factors","volume":"26","author":"Wiendels\u00a0NJ","year":"2006","journal-title":"Cephalalgia"},{"key":"10.1002\/14651858.CD002919.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1745-6215-13-132","article-title":"Developing core outcome sets for clinical trials: issues to consider","volume":"13","author":"Williamson","year":"2012","journal-title":"Trials"},{"issue":"9","key":"10.1002\/14651858.CD002919.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1212\/01.WNL.0000123262.96132.FC","article-title":"Analgesic overuse among subjects with headache, neck, and low-back pain","volume":"62","author":"Zwart","year":"2004","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD002919.pub3-BIB0088|cit88","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002919.pub2","article-title":"Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches","author":"Cusi","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD002919.pub3-BIB0089|cit89","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002919.pub2","article-title":"Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches","author":"Moja","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD002919.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T02:32:10Z","timestamp":1782700330000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD002919.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Pain, Palliative and Supportive Care Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,4,1]]},"references-count":89,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd002919.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,1]]}}}